Concepedia
Statistics
Publications
4
Citations
182
H-Index
Active since
2022
Affiliations
Central South University(Current)
Second Xiangya Hospital of Central South University
Huazhong University of Science and Technology
Wuhan Union Hospital
Union Hospital
Mou Peng is an author at Central South University specializing in molecular oncology, oncology, and neoplasia.
Publications per year
2022–2023
YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway
Wei Li, Kun Ye, Xurui Li et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 71 citations · Full text
Medicine, Oncology, Pharmacology +17
OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIs
Wentao Liu, Bin Yan, Haixin Yu et al. · International Journal of Biological Sciences · 2022 · 66 citations · Full text
The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression
Bin Yan, Xurui Li, Mou Peng et al. · Experimental & Molecular Medicine · 2023 · 32 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis
Yapeng Wang, Mou Peng, Yawen Zhong et al. · Oncogene · 2023 · 13 citations
Life Sciences, Biochemistry, Molecular Biology +7
1–4 of 4